AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2016
Dec 2, 2016
30016_dirs_2016-12-02_ba518f54-e614-4cca-8f94-b6dab67fc741.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2016-11-30
Reporting Person: Studer Jacqueline (CVP, Gen. Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-30 | Common Stock | M | 800 | $79.54 | Acquired | 2974 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-30 | Incentive Stock Option (right-to-buy) | $79.54 | M | 800 | Disposed | 2025-02-13 | Common Stock (800) | Direct |
Footnotes
F1: Includes 52 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2016.
F2: Grant of option to buy 3,140 shares of IDEXX Laboratories, Inc. common stock that vests and is exercisable in five equal annual installments beginning on February 14, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F3: Not applicable.